Central serous chorioretinopathy: what we have learnt so far-Reference-Cited by-同舟云学术

Central serous chorioretinopathy: what we have learnt so far

Published:2015-07-01 Issue:4 Volume:94 Page:321-325
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:Acta Ophthalmol

Author:

Wong Kah Hie¹,Lau Kin Pong¹,Chhablani Jay²,Tao Yong³,Li Qing¹,Wong Ian Y.¹

Affiliation:

1. Department of Ophthalmology; LKS Faculty of Medicine; The University of Hong Kong; Hong Kong Hong Kong

2. Smt. Kanuri Santhamma Retina Vitreous Centre; L. V. Prasad Eye Institute; Hyderabad India

3. Department of Ophthalmology; People's Hospital; Peking University and Key Laboratory of Vision Loss and Restoration; Ministry of Education; Beijing China

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Reference36 articles.

1. A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy;Bae;Am J Ophthalmol,2011

2. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial;Bae;Ophthalmology,2014

3. Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy;Behnia;Retina,2013

4. Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study;Bousquet;Retina,2013

5. The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy;Breukink;Acta Ophthalmol,2014

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central serous chorioretinopathy secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS);Expert Opinion on Drug Safety;2024-08-02

2. Elderly Patient With Bilateral Central Serous Chorioretinopathy Misdiagnosed as Bilateral Wet Age-Related Macular Degeneration: A Case Report;Cureus;2024-07-10

3. Comparison of prevalent management options to treat acute central serous chorioretinopathy;Indian Journal of Ophthalmology;2023-10-20

4. Choriocapillaris Reperfusion in Resolved Chronic Central Serous Chorioretinopathy Treated with Eplerenone: Long-Term Effects on the Fellow Eye;Ophthalmology and Therapy;2023-09-25

5. Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies;Eye and Vision;2023-07-11